Chemist H1B salary at Novitium Pharma LLC
Novitium Pharma LLC offered a median $78,770 for Chemist roles on 25 certified, full-time H1B Labor Condition Applications in FY2024 (Oct 2023 – Sep 2024), per U.S. Department of Labor records.
Updated USCIS data through 2025DOL LCA data through
Chemist offers at Novitium Pharma LLC
Where Novitium Pharma LLC files Chemist roles, FY2024
- East Windsor, NJ23 filings$79K median
- East Widnsor, NJ2 filings
Median and middle 50% by year
- FY2023$69K$65K–$73K
- FY2024$79K$79K–$81K
| Fiscal year | Filings | Median | Middle 50% | Top 10% | Range |
|---|---|---|---|---|---|
| FY2024 | 25 | $78,770 | $79K–$81K | $95K+ | $70K–$140K |
| FY2023 | 4 | $68,500 | $65K–$73K | $74K+ | $65K–$75K |
These are wages offered on the Labor Condition Application (Form ETA-9035), annualized, not salaries actually paid. Certified full-time H1B filings for this job title only; fiscal years with fewer than 3 such filings are left out. Fiscal years run October to September. Source: U.S. Department of Labor, Office of Foreign Labor Certification disclosure data.
Other H1B salaries at Novitium Pharma LLC
Common questions about Chemist pay at Novitium Pharma LLC
How much does Novitium Pharma LLC pay H1B Chemist workers?
The median wage Novitium Pharma LLC offered for Chemist roles on its 25 certified, full-time H1B Labor Condition Applications in fiscal year 2024 was $78,770. The middle half of offers were between $78,770 and $81,000, and the top 10% were above $95,000, per U.S. Department of Labor records.
Has Novitium Pharma LLC's H1B pay for Chemist roles gone up?
The median offered wage went up 15%, from $68,500 in fiscal year 2023 to $78,770 in fiscal year 2024.
Where does Novitium Pharma LLC hire H1B Chemist workers?
In fiscal year 2024, Novitium Pharma LLC's Chemist filings were mostly for East Windsor, NJ (23 filings, $78,770 median) and East Widnsor, NJ (2 filings).
How many H1B applications has Novitium Pharma LLC filed for Chemist roles?
29 certified, full-time H1B Labor Condition Applications across fiscal years 2023–2024, counting years with at least 3 filings for the title.